Trial Outcomes & Findings for The Effects of Alcohol Consumption on Central Adiposity (NCT NCT03521817)

NCT ID: NCT03521817

Last Updated: 2020-06-17

Results Overview

change in visceral abdominal adipose tissue from baseline to post intervention

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

12 participants

Primary outcome timeframe

8 weeks

Results posted on

2020-06-17

Participant Flow

Participant milestones

Participant milestones
Measure
Alcohol
Etoh will have a 30% reduction in calories from weight maintenance and will consume the same percentage of each traditional macronutrient (20% protein, 50% carbohydrate, and 30% fat; (minus the \~240 kcals from ethanol). The Etoh group will consume a 30% energy restriction diet that will also include \~2.5 standard drinks, or 35 grams of ethanol, administered as 80-proof distilled spirits (e.g. 80 proof gin, rum, vodka, whiskey, or tequila). Alcohol: The ethanol group will consume a 30% energy restriction diet that will also include \~2.5 standard drinks, or 35 grams of ethanol, administered as 80-proof distilled spirits (e.g. 80 proof gin, rum, vodka, whiskey, or tequila). In the United States, one "standard" drink contains roughly 14 grams of pure alcohol.
No Alcohol
No Etoh will have a 30% reduction in calories from weight maintenance and will consume the same percentage of each traditional macronutrient (20% protein, 50% carbohydrate, and 30% fat). No Alcohol: This group will not consume alcohol. Thus 0 kcal/d will come from alcohol
Overall Study
STARTED
7
5
Overall Study
COMPLETED
7
4
Overall Study
NOT COMPLETED
0
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Alcohol
Etoh will have a 30% reduction in calories from weight maintenance and will consume the same percentage of each traditional macronutrient (20% protein, 50% carbohydrate, and 30% fat; (minus the \~240 kcals from ethanol). The Etoh group will consume a 30% energy restriction diet that will also include \~2.5 standard drinks, or 35 grams of ethanol, administered as 80-proof distilled spirits (e.g. 80 proof gin, rum, vodka, whiskey, or tequila). Alcohol: The ethanol group will consume a 30% energy restriction diet that will also include \~2.5 standard drinks, or 35 grams of ethanol, administered as 80-proof distilled spirits (e.g. 80 proof gin, rum, vodka, whiskey, or tequila). In the United States, one "standard" drink contains roughly 14 grams of pure alcohol.
No Alcohol
No Etoh will have a 30% reduction in calories from weight maintenance and will consume the same percentage of each traditional macronutrient (20% protein, 50% carbohydrate, and 30% fat). No Alcohol: This group will not consume alcohol. Thus 0 kcal/d will come from alcohol
Overall Study
Protocol Violation
0
1

Baseline Characteristics

The Effects of Alcohol Consumption on Central Adiposity

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Alcohol
n=7 Participants
Etoh will have a 30% reduction in calories from weight maintenance and will consume the same percentage of each traditional macronutrient (20% protein, 50% carbohydrate, and 30% fat; (minus the \~240 kcals from ethanol). The Etoh group will consume a 30% energy restriction diet that will also include \~2.5 standard drinks, or 35 grams of ethanol, administered as 80-proof distilled spirits (e.g. 80 proof gin, rum, vodka, whiskey, or tequila). Alcohol: The ethanol group will consume a 30% energy restriction diet that will also include \~2.5 standard drinks, or 35 grams of ethanol, administered as 80-proof distilled spirits (e.g. 80 proof gin, rum, vodka, whiskey, or tequila). In the United States, one "standard" drink contains roughly 14 grams of pure alcohol.
No Alcohol
n=5 Participants
No Etoh will have a 30% reduction in calories from weight maintenance and will consume the same percentage of each traditional macronutrient (20% protein, 50% carbohydrate, and 30% fat). No Alcohol: This group will not consume alcohol. Thus 0 kcal/d will come from alcohol
Total
n=12 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
7 Participants
n=5 Participants
5 Participants
n=7 Participants
12 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
32 years
STANDARD_DEVIATION 9 • n=5 Participants
31 years
STANDARD_DEVIATION 7 • n=7 Participants
32 years
STANDARD_DEVIATION 8 • n=5 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
5 Participants
n=7 Participants
12 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Race (NIH/OMB)
White
4 Participants
n=5 Participants
4 Participants
n=7 Participants
8 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 8 weeks

change in visceral abdominal adipose tissue from baseline to post intervention

Outcome measures

Outcome measures
Measure
Alcohol
n=7 Participants
Etoh will have a 30% reduction in calories from weight maintenance and will consume the same percentage of each traditional macronutrient (20% protein, 50% carbohydrate, and 30% fat; (minus the \~240 kcals from ethanol). The Etoh group will consume a 30% energy restriction diet that will also include \~2.5 standard drinks, or 35 grams of ethanol, administered as 80-proof distilled spirits (e.g. 80 proof gin, rum, vodka, whiskey, or tequila). Alcohol: The ethanol group will consume a 30% energy restriction diet that will also include \~2.5 standard drinks, or 35 grams of ethanol, administered as 80-proof distilled spirits (e.g. 80 proof gin, rum, vodka, whiskey, or tequila). In the United States, one "standard" drink contains roughly 14 grams of pure alcohol.
No Alcohol
n=3 Participants
No Etoh will have a 30% reduction in calories from weight maintenance and will consume the same percentage of each traditional macronutrient (20% protein, 50% carbohydrate, and 30% fat). No Alcohol: This group will not consume alcohol. Thus 0 kcal/d will come from alcohol
Change in Central (Abdominal) Adiposity
-0.250 kg
Standard Error 0.115
-0.071 kg
Standard Error 0.075

Adverse Events

Alcohol

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

No Alcohol

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Alcohol
n=7 participants at risk
Etoh will have a 30% reduction in calories from weight maintenance and will consume the same percentage of each traditional macronutrient (20% protein, 50% carbohydrate, and 30% fat; (minus the \~240 kcals from ethanol). The Etoh group will consume a 30% energy restriction diet that will also include \~2.5 standard drinks, or 35 grams of ethanol, administered as 80-proof distilled spirits (e.g. 80 proof gin, rum, vodka, whiskey, or tequila). Alcohol: The ethanol group will consume a 30% energy restriction diet that will also include \~2.5 standard drinks, or 35 grams of ethanol, administered as 80-proof distilled spirits (e.g. 80 proof gin, rum, vodka, whiskey, or tequila). In the United States, one "standard" drink contains roughly 14 grams of pure alcohol.
No Alcohol
n=5 participants at risk
No Etoh will have a 30% reduction in calories from weight maintenance and will consume the same percentage of each traditional macronutrient (20% protein, 50% carbohydrate, and 30% fat). No Alcohol: This group will not consume alcohol. Thus 0 kcal/d will come from alcohol
Respiratory, thoracic and mediastinal disorders
Sinus Congestion
0.00%
0/7 • From baseline to completion of study 8 weeks later. Furthermore follow-up calls and emails (not in person visits) were performed post study. Thus total period of time adverse event data were collected was 12 weeks.
20.0%
1/5 • Number of events 1 • From baseline to completion of study 8 weeks later. Furthermore follow-up calls and emails (not in person visits) were performed post study. Thus total period of time adverse event data were collected was 12 weeks.
Skin and subcutaneous tissue disorders
Pruritis (itching)
0.00%
0/7 • From baseline to completion of study 8 weeks later. Furthermore follow-up calls and emails (not in person visits) were performed post study. Thus total period of time adverse event data were collected was 12 weeks.
20.0%
1/5 • Number of events 1 • From baseline to completion of study 8 weeks later. Furthermore follow-up calls and emails (not in person visits) were performed post study. Thus total period of time adverse event data were collected was 12 weeks.
Respiratory, thoracic and mediastinal disorders
Upper respiratory complaints (cold)
14.3%
1/7 • Number of events 1 • From baseline to completion of study 8 weeks later. Furthermore follow-up calls and emails (not in person visits) were performed post study. Thus total period of time adverse event data were collected was 12 weeks.
0.00%
0/5 • From baseline to completion of study 8 weeks later. Furthermore follow-up calls and emails (not in person visits) were performed post study. Thus total period of time adverse event data were collected was 12 weeks.

Additional Information

John W Apolzan

Pennington Biomedical Research Center

Phone: 225-763-2827

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place